Overview Financials News + Filings Key Docs Charts Ownership Insiders
|
|
CATALYST HEALTH SOLUTIONS, INC. (CHSI)
|
Add to portfolio |
|
|
|
| Price: |
$54.70
| | Metrics |
| OS: |
50.6
|
M
| |
8
|
% ROE
|
| Market cap: |
$2.77
|
B
| |
19
|
% ROIC
|
|
Net debt:
|
$481
|
M
| |
3.1
|
x Debt/EBITDA
|
|
EV:
|
$3.25
|
B
| | | |
| | | | | |
| TTM Valuation | | | |
|
EBITDA
|
$157
|
M
| |
20.7
|
x EV/EBITDA
|
|
EBIT
|
$108
|
M
| |
30.1
|
x EV/EBIT
|
| EPS |
$1.35
| |
40.6
|
x P/E
|
|
|
| |
|
|
|
Recent News + Filings (All items)
|
Revenue Mix by Segment
|
Financial Summary (All financials)
| In millions, except per share items | Dec-31-11 | Dec-31-10 | Dec-31-09 | Dec-31-08 | Dec-31-07 | Dec-31-06 | Dec-31-05 | Dec-31-04 |
| Revenues | 5,329.6 | 3,764.1 | 2,894.4 | 2,543.4 | 1,857.7 | 1,271.0 | 694.5 | 521.3 |
| Revenue growth | 41.6% | 30.0% | 13.8% | 36.9% | 46.2% | 83.0% | 33.2% | 35.7% |
| Cost of goods sold | 5,021.7 | 3,529.8 | 2,708.6 | 2,400.1 | 1,747.3 | 1,176.9 | 627.2 | 471.9 |
| Gross profit | 307.9 | 234.2 | 185.8 | 143.3 | 110.4 | 94.1 | 67.3 | 49.4 |
| Gross margin | 5.8% | 6.2% | 6.4% | 5.6% | 5.9% | 7.4% | 9.7% | 9.5% |
| Selling, general and administrative | 193.7 | 101.7 | 81.0 | 67.8 | 54.0 | 46.4 | 32.5 | 24.4 |
| EBITA | 145.6 | 143.2 | 111.7 | 80.8 | 60.7 | 50.8 | 36.7 | 26.5 |
| EBITA margin | 2.7% | 3.8% | 3.9% | 3.2% | 3.3% | 4.0% | 5.3% | 5.1% |
| Amortization of intangibles | 31.4 | 10.7 | 7.0 | 5.4 | 4.3 | 3.0 | 1.9 | 1.6 |
| EBIT | 114.2 | 132.5 | 104.7 | 75.4 | 56.4 | 47.7 | 34.8 | 25.0 |
| EBIT margin | 2.1% | 3.5% | 3.6% | 3.0% | 3.0% | 3.8% | 5.0% | 4.8% |
| Pre-tax income | 107.0 | 130.4 | 105.0 | 79.7 | 63.0 | 52.0 | 36.1 | 26.3 |
| Income taxes | 40.4 | 49.5 | 39.8 | 29.3 | 23.7 | 20.4 | 13.2 | 9.9 |
| Tax rate | 37.7% | 37.9% | 37.9% | 36.7% | 37.6% | 39.3% | 36.4% | 37.7% |
| Net income | 67.0 | 81.0 | 65.2 | 50.4 | 39.3 | 31.6 | 23.0 | 16.4 |
| Net margin | 1.3% | 2.2% | 2.3% | 2.0% | 2.1% | 2.5% | 3.3% | 3.1% |
| |
| Diluted EPS | $1.39 | $1.82 | $1.48 | $1.16 | $0.91 | $0.75 | $0.56 | $0.45 |
| Shares outstanding (diluted) | 48.1 | 44.5 | 43.9 | 43.6 | 43.0 | 42.3 | 41.4 | 36.4 |
| |
| EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges. |
|
|